Comparative effectiveness of extended release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients.

Rachael K Ross Edward V NunesMark OlfsonMatisyahu ShulmanNoa KrawczykElizabeth A StuartKara E Rudolph

Published in: medRxiv : the preprint server for health sciences (2024)

Longer medication retention is important because risks of negative outcomes are elevated after discontinuation. Our results support selection of SL-BUP over XR-NTX. However, most patients discontinued medication by 6 months indicating that more effective tools are needed to improve medication retention, particularly after initiation with XR-NTX, and to identify which patients do best on which medication.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
healthcare
type diabetes
emergency department
metabolic syndrome
adverse drug
adipose tissue
insulin resistance
patient reported